Abstract
Acute myocardial infarction (AMI) is the most frequent cause of death worldwide. The timely diagnosis of AMI, especially ST-segment elevation myocardial infarction, is a key to successful management. A 12-lead electrocardiography (ECG) should be obtained and interpreted as soon as possible. The 12 lead ECG diagnosis may be more difficult in patients without diagnostic ST-segment elevation but with persistent typical ischemic symptoms. Here, we present a diabetic patient with AMI where the ST-segment elevation was masked by glibenclamide (glyburide) initially and delayed ECG change was revealed after glibenclamide was eliminated.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
